Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 28, 2020
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
[ Wed, Oct 28th 2020
] - WOPRAI
Tue, October 27, 2020
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
David Nierengarten Upgraded (ANAB) to Buy and Increased Target to $35 on, Oct 27th, 2020
David Nierengarten of Wedbush, Upgraded "AnaptysBio, Inc." (ANAB) to Buy and Increased Target from $20 to $35 on, Oct 27th, 2020.
David has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $36 on, Wednesday, October 14th, 2020
